修复缺失的部分：进展性多发性硬化症中的神经干细胞的神经保护作用。
Repair what is lost: Neuroprotection through neural stem cells in progressive MS.
机构信息
MS Center Amsterdam, Anatomy and Neurosciences, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
出版信息
Cell Rep Med. 2023 Mar 21;4(3):100985. doi: 10.1016/j.xcrm.2023.100985.
Abstract
Genchi et al. report the first phase 1 trial of neural stem cell transplantation in multiple sclerosis showing a reduction in gray matter atrophy. Results give hope for a new era of induced neuroprotection, especially in progressive multiple sclerosis.
摘要
根奇等人报告了首例多发性硬化症神经干细胞移植的 1 期临床试验，结果显示其可减少灰质萎缩。这些结果为诱导神经保护的新时代带来了希望，特别是在进展性多发性硬化症中。
相似文献
1
Repair what is lost: Neuroprotection through neural stem cells in progressive MS.修复缺失的部分：进展性多发性硬化症中的神经干细胞的神经保护作用。
Cell Rep Med. 2023 Mar 21;4(3):100985. doi: 10.1016/j.xcrm.2023.100985.
2
A neural stem-cell treatment for progressive multiple sclerosis.一种用于进行性多发性硬化症的神经干细胞疗法。
Nat Med. 2023 Jan;29(1):27-28. doi: 10.1038/s41591-022-02164-9.
3
Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis.神经干细胞疗法治疗进展性多发性硬化症的前景与局限。
Trends Mol Med. 2020 Oct;26(10):898-912. doi: 10.1016/j.molmed.2020.04.005. Epub 2020 May 21.
4
Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis.间充质干细胞移植对进展性多发性硬化症脑脊液生物标志物的影响。
Stem Cells Transl Med. 2022 Mar 3;11(1):55-58. doi: 10.1093/stcltm/szab017.
5
Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.自体间充质干细胞移植治疗活动期进展性多发性硬化的疗效。
Brain. 2020 Dec 1;143(12):3574-3588. doi: 10.1093/brain/awaa333.
6
Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis.I 期临床试验：向进展性多发性硬化患者的侧脑室中移植同种异体神经干细胞。
Cell Stem Cell. 2023 Dec 7;30(12):1597-1609.e8. doi: 10.1016/j.stem.2023.11.001. Epub 2023 Nov 27.
7
Modelling multiple sclerosis using induced pluripotent stem cells.使用诱导多能干细胞来模拟多发性硬化症。
J Neuroimmunol. 2020 Dec 15;349:577425. doi: 10.1016/j.jneuroim.2020.577425. Epub 2020 Oct 17.
8
Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.复发缓解型和原发进展型多发性硬化症患者皮质-纹状体-丘脑网络及感觉运动网络中的灰质萎缩
Neuropsychol Rev. 2021 Dec;31(4):703-720. doi: 10.1007/s11065-021-09479-3. Epub 2021 Feb 13.
9
Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection.多种策略提高多发性硬化症中干细胞移植的疗效：聚焦间充质干细胞和神经保护。
J Neuroimmunol. 2019 Mar 15;328:20-34. doi: 10.1016/j.jneuroim.2018.11.015. Epub 2018 Dec 1.
10
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.免疫消融和自体造血干细胞移植对多发性硬化症脑灰质和白质萎缩的影响。
Mult Scler. 2018 Jul;24(8):1055-1066. doi: 10.1177/1352458517715811. Epub 2017 Jun 15.
引用本文的文献
1
Current state of stem cell research in non-human primates: an overview.非人灵长类动物干细胞研究的现状：综述
Med Rev (2021). 2023 Nov 6;3(4):277-304. doi: 10.1515/mr-2023-0035. eCollection 2023 Aug.
本文引用的文献
1
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study.神经干细胞移植治疗进展性多发性硬化症患者的开放性 1 期研究。
Nat Med. 2023 Jan;29(1):75-85. doi: 10.1038/s41591-022-02097-3. Epub 2023 Jan 9.
2
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis.多发性硬化首次脱髓鞘事件后，与复发活动无关的早期进展与长期残疾相关。
JAMA Neurol. 2023 Feb 1;80(2):151-160. doi: 10.1001/jamaneurol.2022.4655.
3
Multiple sclerosis progression: time for a new mechanism-driven framework.多发性硬化症的进展：是时候建立一个新的基于机制的框架了。
Lancet Neurol. 2023 Jan;22(1):78-88. doi: 10.1016/S1474-4422(22)00289-7. Epub 2022 Nov 18.
4
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.脑萎缩与复发缓解型多发性硬化患者疾病进展的相关性，与复发活动无关。
JAMA Neurol. 2022 Jul 1;79(7):682-692. doi: 10.1001/jamaneurol.2022.1025.
5
The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial dataset. timed 25-foot walk 比 EDSS 更能敏感地反映 PPMS 临床试验的结果：对 PROMISE 临床试验数据集的分析。
J Neurol. 2022 Oct;269(10):5319-5327. doi: 10.1007/s00415-022-11171-2. Epub 2022 May 16.
6
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.进展性多发性硬化症患者的脑脊液降低少突胶质前体细胞的分化和免疫功能。
Glia. 2022 Jun;70(6):1191-1209. doi: 10.1002/glia.24165. Epub 2022 Mar 9.
7
Identifying Progression in Multiple Sclerosis: New Perspectives.多发性硬化症的进展识别：新视角。
Ann Neurol. 2020 Sep;88(3):438-452. doi: 10.1002/ana.25808. Epub 2020 Jul 6.
8
Can CSF biomarkers predict future MS disease activity and severity?脑脊液生物标志物能否预测未来的多发性硬化症疾病活动和严重程度？
Mult Scler. 2020 Apr;26(5):582-590. doi: 10.1177/1352458519871818. Epub 2020 Jan 22.
9
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.非清髓性造血干细胞移植与继续疾病修正治疗对复发缓解型多发性硬化症患者疾病进展的影响：一项随机临床试验。
JAMA. 2019 Jan 15;321(2):165-174. doi: 10.1001/jama.2018.18743.
10
Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis.注射成年神经球可在多发性硬化症的慢性模型中诱导恢复。
Nature. 2003 Apr 17;422(6933):688-94. doi: 10.1038/nature01552.
Zotero 插件